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The cellular uptake of a model antisense oligonuclcotide complementary to 21 bases of the bovine GLUT-l glucose transporter mRNA and a 
model vasoprcssin peptide that were biotinylated. was markedly stimulated by the presence of avidin, a cationic protein. Conversely, the bacterial 
homologue of avidin, streptavidin, which is a slightly acidic protein, did not facilitate cellular uptake. The avidin-mediated uptake of biotinylated 
derivatives was competitively inhibited by another cationic protein, protamine, with a Ki of 5 &ml; was saturable, temperature- and time-depend- 
ent; and was associated with endocytosis. The use of the avidin-biotin system provides a new approach to increasing the ceIluIar uptake of antisense 
oligonucleotides or peptides. 
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1. I[NTRODUCTION 
Antisense oligonucleotides or peptides are potential 
highly specific chemotherapeutic agents for the treat- 
ment of cancer, viral infections, and other disorders 
[1,3]. However, a major problem limiting the 
therapeutic efficacy of these agents in vivo is the 
minimal cellular uptake of the highly charged 
oligonucleotide or peptide compounds. It may be ad- 
vantageous to conjugate the antisense oligonucleotide 
to a transport vector via high affinity binding that is 
stable in the circulation but is labile in cells. Such a bin- 
ding underlies the avidin-biotin interaction, as previous 
studies have shown the avidin-biotin binding reaction, 
(& = IO-l5 M) [4], is stable in the circulation [S]. In ad- 
dition, avidin is a cationic protein with an isoelectric 
point (PI) of 10 (41, and cationic proteins are taken up 
by cells via an absorptive-mediated endocytosis 
mechanism [6]. Therefore, the present studies examine 
the feasibility of using avidin-biotin technology to 
enhance cellular uptake of antisense oligonucleotides or 
peptides. 
2. MATERIALS AND METHODS 
2. I Mabzrials 
The model antiscnsc oligonucleotidc used in these studies is a 
tl-mcr complcmcntary to the bovine GLUT-I glucose transporter 
niRNA 171, and it corresponds to nuclcolidcs -9 to + I2 (+ 1 
rcprcscnts the first nuclcotidc of the nlcthionine initiation codon), 
whcrcin the thyminc base that pairs to - 1Oof the mRNA is rcplaccd 
by 6.amino uracil (au) suitable for biotinylation ncnr the 5’.end of 
the antisensc oligonuclcotidc. The oligonuclcolidc, wirh the scqucncc 
5’.GGaUGGGCTCCATGGCCGCGCT-3’, wns custom-syntlicsizcd 
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by Genosys Biotechnologies, Inc. (The !‘!c&!ands, TX). The model 
vasopressin analogue, [desamino-Cys’,D-Lysa]lysine vasopressin 
(DDLVP) was custom-synthesized by Peninsula Laboratories (Bel- 
mont, CA). Sulfo-succinimidyl-2-(biotinamido)ethyl- I ,3-dithiopro- 
prionate (NHS-SS-biotin) and N-hydroxysuccinimidobiotin (NHS- 
biotin) were purchased from Pierce Chemical Co. (Rockford, IL). 
[‘rsl]iodine, 13H]biotin (sp. act. 45 mCi/fimol), and [y-32P]ATP were 
purchased from DuPont-NEN (Boston, MA). Avidin, streptavidin, 
cu-methylmannoside (cuMM), salmon protamine (Grade 4). and other 
reagents were obtained from Sigma Chemical Co. (St. Louis, MO). 
Millex GV 0.22 p filters were obtained from Millipore Corp. (Bed- 
ford, MA). 
2.2. Synthesis of biolinylrrted oligomers 
The antisense oligonucleotide was biotinylated with NHS-biotin 
IS]. Following biotinylation, the product was purified by Sephadex 
G-25 gel filtration and labeled at the 5’.end with polynucleotide TJ 
kinase using [y-3zP]ATP, and this labeling resulted in a final product 
with a specific activity of 2.6 &i/pmol. The labeled oligonucleotide 
was re-purified through a Sephadex G-25 column, avidin was added, 
and the avidin/bio-DNA complex was purified by Sephadex G-75 
column chromatography prior 10 experiments, where bio- 
DNA = biotinylated oligonucleotide, The DDLVP was purified to 
homogeneity by Cl8 reverse-phase high-performance liquid 
chromatography (HPLC), radiolabcled with [‘2’l]iodine and 
choramine T, followed by purification through a Cl8 Sep Pak extrac- 
tion cartridge, and was biotinylated with NHS-SS-biotin [9]. 
Two different types of blorin annlogues wcrc employed in these 
studies. The antiscnse oligonucleotidc was biolinylated with NHS- 
biotin, and this biotinylarion reaction results in the formation of an 
avidin-biotin conjugate that is resistant to thiol cleavage. The 
DDLVP was biolinylarcd with a clcavablc biotin linker ctnploying 
NHS-SS-biotin, and this results in the formation of a dirulfidc-based 
linker that allows for thiol-based clcavagc of the biotinylated drug 
frolii the avidin vcc(or [B-IO]. 
2.3. 13irtditrg studies with isolarcd brain capillaries 
Capillaries wcrc isolated from fresh bovine brain cortex using ;I 
mechanical homogcnitaliotr rcchnlquc as dcscribcd previously [6]. 
The isolated bralrl capillaries wcrc Incubated III Rlegcr-HEPES buf- 
fcr (RHU) containing cithcr (‘l~l]avldit~ (O,Z/rCi/nrl), [‘Hjbiotia (0.5 
/Ki/nil), [“‘IJbio-SS-DDLVP (0.5 /K.i/all), or (“PJbio-DNA (0.2 
&i/ml), along with various <onccnlrations of u~~lehclcd avidin, 
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streptavidin. or a-methylmannoside (~YMM). Unless otherwise in- 
dicated, all incubations were performed at 23°C for 30 min, and the 
amount of brain capillaries added per 0.45 ml incubation reaction cor- 
responded to approximately 100 /rg protein per tube. The data are 
reported as mean 2 SE (n= 3 per point). Following incubation of 
capillaries for 5 s to 30 min at either 37OC or 4”C, endocytosis of 
[‘HJbiotin-avidin was measured using an acid wash assay described 
previously [6]. 
2.4. Avidin mdio-iodinatiotr 
Avidin was iodinated with ‘*‘I and chloramine T to a specific activi- 
ty of 2.0 /tCi/eg. The final product was 95% precipitable with 
trichloroacetic acid (TCA). 
3. RESULTS 
The brain capillary uptake of 13H]biotin is negligible 
in the presence of Ringer-HEPES buffer alone 
(Fig. 1B). However, when avidin is added to incuba- 
tion, the brain capillaries avidly take up the e3H]bio- 
tin-avidin complex. This uptake is rapid and reaches 
equilibrium at 37’C by 5 min of incubation (Fig. 2), 
and approximately 40% of the uptake of the [3H]bio- 
tin-avidin complex is resistant o a mild acid wash 
(Fig. 2). 
In contrast o avidin, the addition of streptavidin to 
the incubation mixture results in no increased uptake of 
biotic (Fig. 1B). The differences between the cationic 
avidin and the slightly acidic streptavidin, (pI = 5-6) 
[ 111, underscore the importance of the cationic nature 
of avidin which initiate: the absorptive-mediated n- 
docytosis of the avidin-biotin complex by brain 
capillaries (Fig. 2). Similar to other cationic proteins 
such as cationized albumin or histone [6,12], the 
absorptive-mediated ndocytosis of avidin by isolated 
brain capillaries is competitively inhibited by the 
polycationic protein, protamine, with a Ki = 5 #g/ml 
protamine (Fig. 2). 50 mM cu-methyl-mannoside results 
in no significant inhibition of the uptake of the 
avidin-biotin complex by brain capillaries (Fig. 1B). 
The uptake by isolated brain capillaries of either the 
[“‘I]avidin or [3H]biotin bound to unlabeled avidin is 
shown in Fig. IA. The uptake of the 13H]biotin is ap- 
proximately fourfold greater than the uptake of the 
[“‘I]avidin, consistent with four biotin binding sites per 
avidin tetramer [4]. The concentration of avidin which 
results in 50% inhibition of uptake is approximately 
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Fig. I. Avidin-mediated uptake of biolin, biotinylatcd pcptide, and biotinylatcd ontiscnsc oligonuclcotidc by isolated bovine brain capillaries in 
vitro. A. The percent uptake (per mg ptotci!l of isolated brain cupillarics) of either [‘zsl]avidin or [‘H]bio!in is plotted vs the concentration (I-500 
&ml) of avldin in the incubilfion tncdium. (Irrscr) The uptake of cithcr isotope is lirlear with rcspcct 10 the amount of brain capillaries added to 
the incubn[ion nrixturc. III tlicsccxpcrialcnla, [““llavidin is prcscnt at a conccntrallon of 0.1 &ml (1.6 nM)and (‘HJbiotin is prcscnt at a conccn- 
[ration of 22 nM. B, The percent uptake of [“Hlbiotin by isolated bovine breln capillaries is plotted vs the incubation vehicle conialning cithcr 
RHB buffer, avidin, avidin plus 50 mM a-mcrhylmannosidc (wMM), or strcpfovidin. C. The pcrcctrt uptake of [“‘IJbio-SS-DDLVP by isolntcd 
brain capillaries is plortcd vs the incubafion vchiclc, which conraincd cithcr buffer, avldin, or avidin plus dlthiothrcitol (DTT) prc-treatment. D, 
The pcrccnt uptake of [“PJbiorinylatcd oliganucleotidc (bio.DNA) by isolated bovitrc brain capillaries is plotted vs the incubation vehicle, which 
contains cithcr buffer, ovidin, or strcptavidin. 
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Fig. 2. (Top) The percent uptake of [3H]biotin in the presence of SO0 
nM avidin by isolated bovine brain capillaries is plotted versus the in- 
cubation time at either 37% or 4°C. Both total binding and binding 
that is resistant to a mild acid wash is shown. (Bottom) The percent 
uptake of [‘Hlbiotin in the presence of 1 &ml avidin (16 nM) is in- 
hibited by increasing concentrations of unlabeled salmon protamine, 
and the concentration of protamine that gives 50010 inhibition is S 
p&ml (1.1 GM) protamine. 
350 pg/ml of 5 FM avidin. The horizontal line in 
Fig. 1A represents the nonspecific uptake for an ex- 
tracellular marker such as [3H]sucrose or [3H]albumin. 
In Fig. lC, the uptake by brain capillaries of 
[‘251]bio-SS-DDLVP is negligible in the presence of 
Ringer’s buffer, but is increased in the presence of 500 
nM avidin, In contrast, the pre-treatment of the 
[“‘I]bio-SS-DDLVP-avidin complex with 25 mM 
dithiothreitol (DTT) prior to addition to the isolated 
brain capillary preparation results in a decrease in the 
capillary uptake of the [“‘I]DDLVP peptide. The 
decreased uptake caused by the DTT pre-treatment is
due to cleavage of the disulfide bond, which separates 
the biotinylated DDLVP peptide from the avidin vec- 
tor. In Fig. lD, the uptake of [32P]bio-antisense 
oligonucleotide by isolated brain capillaries is relatively 
low, and this uptake is increased by the addition of 800 
nM avidin to the incubation mixture. Conversely, there 
is no significant increase in uptake when 800 nM sttep- 
tavidin is added to the incubation. The modest uptake 
of radioactivity in the presence of buffer alone may 
represent uptake of [32P]nucleotide or phosphate ion 
gcneratcd by capillary nuclease or phosphatasc degra- 
dation of the antisense oligonucleotide, 
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4. DISCUSSION 
These studies how that avidin undergoes absorptive- 
mediated binding and endocytosis by isolated bovine 
brain capillaries, and the basis for this uptake is the cat- 
ionic nature of the avidin protein. The evidence for this 
is threefold. First, the uptake is competitively inhibited 
by another cationic protein, protamine, with a Ki of 5 
pg/ml (Fig. 2), which is similar to the Ki characterizing 
the protamine inhibition of brain capillary uptake of 
other cationic proteins, such as cationized albumin or 
histone 16,121. Second, the bacterial homologue of 
avidin, streptavidin, which has a 38010 amino acid 
homology with avidin [13], but is a slightly acidic pro- 
tein [l I], does not facilitate cellular uptake of biotin 
(Fig. I). Third, the mannose-rich carbohydrate [14] 
moiety of avidin does not trigger the saturable uptake 
of avidin by isolated brain capillaries ince high concen- 
trations of cu-methylmannoside result in no significant 
inhibition of the uptake of the avidin-biotin complex 
by brain capillaries (Fig. 1). 
The present studies suggest hat the avidin-biotin 
technology may be used to enhance cellular delivery of 
antisense oligonucleotides and peptides. In addition, 
the avidin cDNA has been cloned [ 151, and the produc- 
tion of avidin fusion constructs, wherein the avidin 
gene is fused to that of an organ-specific transport vec- 
tor, may allow for targeted elivery of biotinyIated an- 
tisense oligonucleotides or peptides. 
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